ondansetron has been researched along with Cerebrospinal Fluid Drainage in 1 studies
Ondansetron: A competitive serotonin type 3 receptor antagonist. It is effective in the treatment of nausea and vomiting caused by cytotoxic chemotherapy drugs, including cisplatin, and has reported anxiolytic and neuroleptic properties.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bordlee, JW | 1 |
| Beakley, BD | 1 |
| Mody, R | 1 |
| McConville, AP | 1 |
| Weed, JT | 1 |
| McClure, BP | 1 |
| Foldes, PJ | 1 |
| Ma, JG | 1 |
| Kaye, AD | 1 |
| Eskander, JP | 1 |
1 other study available for ondansetron and Cerebrospinal Fluid Drainage
| Article | Year |
|---|---|
A case of paradoxical presentation of a postural postdural puncture headache after combined spinal-epidural anesthesia.
Topics: Acetaminophen; Adult; Analgesics, Opioid; Anesthesia, Epidural; Anesthesia, Obstetrical; Anesthesia, | 2017 |